Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin for microalbuminuria in type 2 diabetes
IRCT20201028049174N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in diabetic glomerulosclerosis comparing Sitagliptin with Placebo (2 arms). Primary endpoint: Urine Albumin-to-Creatinine Ratio in a random urine sample. Started Mar 2018; status: completed.
02
Drugs
sitagliptin
03
Conditions
diabetic glomerulosclerosis
Beyond the preview
Go deeper on IRCT20201028049174N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201028049174N1.